Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Drug Approval
Advertisement
Blog Post
FDA Approves Reata’s SKYCLARYS for Treatment of FA
By
Sujatha Gurunathan
|
February 28, 2023
Blog Post
MDA Celebrates the Approval of Relyvrio from Amylyx for the Treatment of ALS
By
MDA Staff
|
September 30, 2022
Blog Post
FDA Approves MTPA’s RADICAVA ORS for Treatment of ALS
By
Sujatha Gurunathan
|
May 13, 2022
Featured Article
A Successful In-Person Conference
By
MDA Staff
|
May 13, 2022
FDA Approves Alexion’s Ultomiris for Treatment of gMG
By
Sujatha Gurunathan
|
April 28, 2022
Blog Post
Simply Stated: What is Duchenne Muscular Dystrophy?
By
Sujatha Gurunathan
|
February 16, 2022
Blog Post
FDA Approves argenx’s Vyvgart for Treatment of gMG
By
Sujatha Gurunathan
|
December 20, 2021
Featured Article
Demystifying Drug Prices
By
Larry Luxner
|
November 19, 2021
Blog Post
FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of Pompe Disease
By
MDA Staff
|
August 6, 2021
Blog Post
FDA approves Octapharma’s Octagam® 10% for Treatment of Adults with Dermatomyositis
By
Sujatha Gurunathan
|
July 29, 2021
1
2
3
4
Next »
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset